🔎 Trials Near Me

Akèy › Kansè rektal › Tennessee › Nashville

Etid klinik pou Kansè rektal nan Nashville, TN

9 etid pou Kansè rektal ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • Sarah Cannon Research Institue, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Ap rekriteFaz 1/2
  • Tennessee Oncology, PLLC, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07629960

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Ap rekriteFaz 1/2
  • GSK Investigational Site, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07213609

ColoSeal™ ICD System Anastomotic Protection Pivotal Study

Ap rekrite
  • Vanderbilt University Medical Center, Nashville
Laj 22 a 75 · Tout sèks · Mizajou Aug 21, 2026 · NCT07429110

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Ap rekriteFaz 3
  • Vanderbilt University/Ingram Cancer Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06205485

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Ap rekriteFaz 1/2
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT06051695

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Ap rekriteFaz 2
  • SCRI Oncology Partners, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT07011576

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Sarah Cannon Research Institute, Nashville
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06239194

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Nashville
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè rektal nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.